The Rapid Uptake Products (RUP) programme supports stronger adoption and spread of NICE approved proven innovations targeting clinical priorities as set out in the NHS Long Term Plan.

The 2021/22 supported RUPs are: Lipid Management, a NICE-endorsed clinical pathway to help reduce cholesterol; Asthma Biologics, a treatment for severe Asthma and FeNO testing, which aids diagnosis of Asthma. Funding has to date been made available for the three RUPs.

For the latest update visit:
https://www.england.nhs.uk/aac/what-we-do/how-can-the-aac-help-me/pathway-transformation-fund/